Binding assays with fibronectin‐coated surfaces, competing RGD peptides, and integrin β6‐neutralizing antibodies confirmed the crucial role of β6‐fibronectin binding in the interaction between tumour cells and EC. This evidence concerns the gene FN1 and neoplasm.